“This lens represents an important step forward for our patients,” said Dr. Steven J. Dell. “The TECNIS PureSee™ IOL offers something genuinely new: a premium extended depth of focus lens that doesn’t ...
The Vision business at Johnson & Johnson MedTech has hit its latest milestone, earning a significant regulatory nod for its ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this Healio Video Perspective from the AAO meeting, Daniel H. Chang, MD, of Empire Eye and Laser ...
ClearSight is now offering the Tecnis Odyssey Lens, a next-generation intraocular lens (IOL) designed for patients undergoing cataract surgery or Custom Lens Replacement. This advanced lens technology ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens ...
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Johnson & Johnson (NYSE:JNJ) received FDA approval for its ...
ABBOTT PARK, Ill., April 18, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the TECNIS ® Toric 1-Piece intraocular lens (IOL) has received U.S. Food and Drug Administration (FDA) ...
Launched in the month of World Sight Day, this next-generation monofocal intraocular lens is an advanced solution for post cataract surgery patients, that helps to meet the changing lifestyle needs of ...